financetom
Business
financetom
/
Business
/
Intel Q1 Swings to Profit, Revenue Increases, Sets Q2 Outlook -- Shares Slump
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Intel Q1 Swings to Profit, Revenue Increases, Sets Q2 Outlook -- Shares Slump
Apr 25, 2024 1:44 PM

04:23 PM EDT, 04/25/2024 (MT Newswires) -- Intel ( INTC ) reported Q1 non-GAAP net income Thursday of $0.18 per share, compared with a loss of $0.04 a year earlier.

Analysts polled by Capital IQ expected $0.14.

Net revenue for the quarter ended March 30 was $12.72 billion, up from $11.72 billion a year earlier.

Analysts surveyed by Capital IQ expected $12.78 billion.

Intel ( INTC ) is projecting Q2 non-GAAP EPS of $0.10 per share on revenue between $12.5 billion and $13.5 billion. Analysts polled by Capital IQ expect earnings of $0.26 per share on revenue of $13.59 billion.

The company's board kept the quarterly dividend at $0.125 per share, payable on June 1 to shareholders of record on May 7.

Intel ( INTC ) shares were down more than 8% in recent after-hours activity.

Price: 32.14, Change: -2.97, Percent Change: -8.46

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US judge should reject Boeing plea deal, crash victim families say
US judge should reject Boeing plea deal, crash victim families say
Jul 25, 2024
July 25 (Reuters) - U.S. District Judge Reed O'Connor should reject a sweetheart plea deal the Justice Department struck with Boeing ( BA ), relatives of some of the 346 people killed in two fatal 737 MAX crashes said on Thursday. Late Wednesday, the planemaker finalized an agreement to plead guilty to a criminal fraud conspiracy charge and pay at...
Becton, Dickinson Partners With Quest Diagnostics on Flow Cytometry-Based Companion Diagnostics
Becton, Dickinson Partners With Quest Diagnostics on Flow Cytometry-Based Companion Diagnostics
Jul 25, 2024
01:46 PM EDT, 07/25/2024 (MT Newswires) -- Becton, Dickinson ( BDX ) and Quest Diagnostics ( DGX ) said Thursday they are collaborating to develop, manufacture and commercialize flow cytometry-based companion diagnostics for cancer and other diseases. The companies said they will aim to provide the pharmaceutical industry with joint offerings ranging from exploratory panel development to the manufacturing and...
Viking Therapeutics Stock Surges As Company Advances Weight Loss Drug To Late-Stage Trial: What Investors Need To Know
Viking Therapeutics Stock Surges As Company Advances Weight Loss Drug To Late-Stage Trial: What Investors Need To Know
Jul 25, 2024
Viking Therapeutics Inc ( VKTX ) shares are rising Thursday after the biotech company announced plans to advance its experimental weight loss drug to late-stage trials. What Happened: After the market close on Wednesday, Viking Therapeutics ( VKTX ) reported financial results for the second quarter that included an update on VK2735, the lead candidate of the company’s unique series...
Vivendi posts H1 growth helped by Lagardère consolidation, Havas
Vivendi posts H1 growth helped by Lagardère consolidation, Havas
Jul 25, 2024
July 25 (Reuters) - French media conglomerate Vivendi reported a 39.3% rise in first-half adjusted operating profit to 619 million euros ($672.30 million) on Thursday, helped notably by consolidation of the publishing group Lagardère and growth in advertising business Havas. WHY IT'S IMPORTANT Vivendi and the Bollore family own a combined 28% stake in the world's biggest music label Universal...
Copyright 2023-2026 - www.financetom.com All Rights Reserved